Abstract： Objective To investigate the effect of small interfering RNA (siRNA) interference in the expression of epidermal growth factor receptor (EGFR) on the radiosensitivity of esophageal squamous carcinoma (Eca-109) and esophageal adenocarcinoma (OE-19) cell lines. Methods Human Eca-109 and OE-19 cell lines were selected as study subjects. Various EGFR-siRNA and negative siRNA were synthesized chemically through lipofection. Reverse transcription-polymerase chain reaction and Western blot were applied to measure the expression of EGFR before and after transfection, and the CCK8 assay was applied to analyze the influence of transfection on cell proliferation. Blank control groups of Eca-109 and OE-19 cells (O1 and O2 groups), simple irradiation groups (R1 and R2 groups), and EGFR-siRNA irradiation groups (E-R1 and E-R2 groups) were set, and the doses for single irradiation were 0, 2, 4, 6, and 8 Gy. The colony-forming assay was applied to calculate survival fraction (SF) and sensitization enhancement ratio (SERD0 ratio), and flow cytometry was applied to evaluate the influence of EGFR-siRNA combined with radiotherapy on cell cycle distribution and apoptosis rate, and the dose for single irradiation was 6 Gy. Results The expression of EGFR in both cell lines was significantly down-regulated by EGFR-siRNA, and the inhibition rate of cell proliferation by transfection was<5%(4.9% and 4.5%, respectively). The results of colony-forming assay showed that the cells in the E-R1 and E-R2 groups had a lower SF than those in the O1 and O2 groups, with an SERD0 ratio of 1.40 and 1.01, respectively. The results from flow cytometry showed that compared with the E-R2 group, the E-R1 group had a higher proportion of cells in G2/M phase and a lower proportion of cells in S phase after irradiation (P=0.016 and 0.028), as well as a higher apoptosis rate (P=0.007). Conclusions Compared with the cell line OE-19, the cell line Eca-109 has a significantly increased radiosensitivity when treated with siRNA interference in EGFR expression.
Li Jiancheng,Qiu Zidan,Pan Dinglong et al. Effect of siRNA interference in EGFR expression on radiosensitivity of human Eca-109 and OE-19 cell lines[J]. Chinese Journal of Radiation Oncology, 2016, 25(1): 76-80.
[1]Dubecz A,Gall I,Solymosi N,et al. Temporal trends in long-term survival and cure rates in esophageal cancer:a SEER database analysis[J].J Thorac Oncol,2012,7(2):443-447.DOI:10.1097/JTO.0b013e3182397751. [2]李建成,张和平,刘迪,等.表皮生长因子受体siRNA对食管鳞癌细胞的放射增敏研究[J].中华放射医学与防护杂志,2013,33(1):23-26.DOI:10.3760/cma.j.issn.0254-5098.2013.01.006. Li JC,Zhang HP,Liu D,et al. Study on the radiosensitization of esophageal squamous cell carcinoma with epidermal growth factor receptor siRNA[J].Chin Radiat Med Prot,2013,33(1):23-26.DOI:10.3760/cma.j.issn.0254-5098.2013.01.006. [3]Pretto G,Gurski RR,Binato M,et al. Increase of epidermal growth factor receptor expression in progression of GERD,Barrett,and adenocarcinoma of esophagus[J].Dig Dis Sci,2013,58(1):115-122.DOI:10.1007/s10620-012-2316-z. [4]Navarini D,Gurski RR,Madalosso CA,et al. Epidermal growth factor receptor expression in esophageal adenocarcinoma:relationship with tumor stage and survival after esophagectomy[J].Gastroenterol Res Pract,2012,2012:941954.DOI:10.1155/2012/941954. [5]Song H,Pan B,Yi J,et al. Autophagic activation with Nimotuzumab enhanced chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma[J].Exp Biol Med (Maywood),2014,239(5):529-541.DOI:10.1177/1535370214525315. [6]Lynam-Lennon N,Reynolds JV,Pidgeon GP,et al. Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma[J].Radiat Res,2010,174(6):703-711.DOI:10.1667/RR2295.1. [7]Bandla S,Pennathur A,Luketich JD,et al. Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma[J].Ann Thorac Surg,2012,93(4):1101-1106.DOI:10.1016/j.athoracsur.2012.01.064. [8]汤钊猷,蒋国良,邵志敏,等.现代肿瘤学[M].3版.上海:复旦大学出版社,2011:799. Tang ZHY,Jiang GL,Shao ZHM,et al. Modern oncology[M].3 ed. Shanghai:Fudan university publishing,2011:799. [9]Chen SJ,Luan J,Zhang HS,et al. EGFR-mediated G1/S transition contributes to the multidrug resistance in breast cancer cells[J].Mol Biol Rep,2012,39(5):5465-5471.DOI:10.1007/s11033-011-1347-4. [10]Hong J,Belkhiri A.AXL mediates TRAIL resistance in esophageal adenocarcinoma[J].Neoplasia,2013,15(3):296-304. DOI:10.1593/neo.122044. [11]Arlt A,Müerkster SS,Schfer H,et al. Targeting apoptosis pathways in pancreatic cancer[J].Cancer Lett,2013,332(2):346-358.DOI:10.1016/j.canlet.2010.10.015.
2016, Vol. 25 
